Company Overview
American HealthCare Capital is pleased to exclusively present an outpatient substance use treatment provider located in Eastern Pennsylvania. The center is fully licensed by the state department of drug and alcohol programs, holds CARF accreditation as an OTP, and maintains both DEA and CSAT registration for dispensing methadone and buprenorphine.
The clinic provides comprehensive medication-assisted treatment (MAT) through a combination of on-site and telehealth services, with 100% of the patient population aged 18 and over. The clinic is approved for up to 625 clients and is currently treating nearly 300 clients, which presents a strong opportunity to increase census and profitability through expanded services, including buprenorphine implants/injections and psychiatric care.
Services & Payor Mix
The clinic’s program components include:
- Medical assessments and individualized treatment planning
- Methadone and buprenorphine dosing
- Individual counseling and behavioral health therapy
- Physician appointments and medication management
- Discharge planning and care coordination
- Telehealth availability for eligible services
Their primary payor is Medicaid/MCOs, followed by Medicare Advantage, and they also accept traditional Medicare, county funding, and self-pay.
Financial Overview
The clinic has experienced steady growth since inception. Revenue is primarily driven by dosing, counseling, and medical services. As of March 2025 (9 month period with a fiscal period ending June 30th), gross revenue has reached $1,030,782, putting them on track to reach $1.4 million by the end of the fiscal year. They are currently showing an operating loss of $300,146 as of March 2025, and these losses reflect continued investment in infrastructure, staffing, and program development. By downsizing the clinic’s footprint this year, overhead has been reduced from $15,000 to $5,000 per month, adding an immediate $120,000 in annual profit. Additionally, a new full-time Program Director (CRNP) has been hired at $90 per hour, compared to last year’s MD at $300 per hour.
The Center is well-positioned for growth through expanded census, the addition of buprenorphine implant/injection services, and psychiatric offerings.
Staff Overview and Exit Plan
Due to distance ownership has made the strategic decision to redirect operational focus and future growth efforts toward their other business interests and will not remain involved with the business post-sale. While some higher-level roles—such as the Executive Director, Nursing Director, Medical Director, Physician, Finance Director, and Staff Accountant—will need to be replaced due to shared staffing with another location, the seller is committed to supporting a smooth transition and will provide assistance during an agreed-upon transition period.
A strong core team will remain in place following the sale, including clinical, administrative, and nursing staff. This provides a stable operational foundation for continued service delivery and facilitates a smooth ownership transition.
Asking Price
The seller will consider all reasonable offers.
